Gedikbaşı Ali, Oztarhan Kazım, Yıldırım Gökhan, Gül Ahmet, Ceylan Yavuz
Clinic of Obstetrics and Gynecology, İstanbul Bakırköy Maternity and Children Diseases Hospital, İstanbul, Turkey.
Anadolu Kardiyol Derg. 2011 Mar;11(2):137-45. doi: 10.5152/akd.2011.035. Epub 2011 Feb 23.
To determine the clinical outcomes and decisions of families of fetuses with prenatally-diagnosed cardiac abnormalities.
Prenatally diagnosed cases (n=155) with congenital heart disease were retrospectively categorized according to the Allan-Huggon grading system: Group A (cardiac disease associated with severe / lethal extracardiac disease); Group B1 (low risk with a postnatal prognosis); Group B2 (moderate risk, amenable to surgical repair with a low mortality); and Group B3 (high risk, associated with high mortality after surgery). Neonatal outcomes, including termination of pregnancy, were recorded for 18 months of follow-up after counseling the parents. Student's t-test, Mann-Whitney U, Pearson's Chi-square test and Fischer's exact Chi-square test were used for statistical analyses.
One hundred forty-five cases completed follow up. Thirty-nine cases (Group A) were associated with extracardiac lethal defects and the pregnancies were terminated; these cases were excluded from statistical evaluation. Twenty parents in Group B3 opted also for termination. The survival rates of ongoing pregnancies after 18 months of follow-up between the three cardiac abnormality Groups (Group B1, n=37; Group B2, n=12; and Group B3, n=37) were 89.2%, 66.7%, and 13.5%, respectively. Significance was present between the survival rates of the three Groups [Group B3 vs. Group B1: p=0.0001; OR: 52.8 (12.9-214.5); Group B3 vs. Group B2: p=0.0009; OR: 12.8 (2.8-58.9); Group B2 vs. Group B1: p=0.087; OR: 4.12 (0.84-20.2)].
Our practice and the findings reported herein support the efficacy of this staging system and counseling parents of fetuses for congenital heart diseases.
确定产前诊断为心脏异常的胎儿家庭的临床结局及决策。
对产前诊断为先天性心脏病的病例(n = 155),根据艾伦 - 哈贡分级系统进行回顾性分类:A组(与严重/致命性心外疾病相关的心脏病);B1组(产后预后低风险);B2组(中度风险,可通过手术修复且死亡率低);B3组(高风险,手术后死亡率高)。在为父母提供咨询后,记录18个月随访期内的新生儿结局,包括终止妊娠情况。采用学生t检验、曼 - 惠特尼U检验、皮尔逊卡方检验和费舍尔精确卡方检验进行统计分析。
145例完成随访。39例(A组)与心外致命缺陷相关,妊娠终止;这些病例被排除在统计评估之外。B3组中有20名父母也选择终止妊娠。三个心脏异常组(B1组,n = 37;B2组,n = 12;B3组,n = 37)在随访18个月后继续妊娠的存活率分别为89.2%、66.7%和13.5%。三组存活率之间存在显著差异[B3组与B1组:p = 0.0001;OR:52.8(12.9 - 214.5);B3组与B2组:p = 0.0009;OR:12.8(2.8 - 58.9);B2组与B1组:p = 0.087;OR:4.12(0.84 - 20.2)]。
我们的实践及本文报告的研究结果支持该分期系统的有效性,以及为先天性心脏病胎儿的父母提供咨询的有效性。